ANTHEM INC's ticker is ANTM and the CUSIP is 036752103. A total of 1,087 filers reported holding ANTHEM INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
About ANTHEM INC
Anthem Inc. is a leading health insurance company in the United States. The company provides a wide range of health insurance products and services to individuals, families, and businesses. Anthem operates in 14 states and has over 40 million members.
Anthem's success can be attributed to its strong leadership team, led by CEO Gail Boudreaux. Boudreaux has been instrumental in driving the company's growth and expansion. Under her leadership, Anthem has made significant investments in technology and innovation, which have helped the company stay ahead of its competitors.
Anthem's financial performance has been impressive in recent years. The company reported revenue of $121 billion in 2020, up from $92 billion in 2016. Anthem's net income has also increased, from $2.5 billion in 2016 to $4.8 billion in 2020.
Anthem's success has not gone unnoticed by investors. The company's stock has performed well in recent years, with a 5-year return of over 100%. Anthem's strong financial performance and leadership team make it an attractive investment opportunity for stock market investors.
In conclusion, Anthem Inc. is a leading health insurance company with a strong leadership team and impressive financial performance. The company's focus on technology and innovation has helped it stay ahead of its competitors, and its stock has performed well in recent years. For stock market investors looking for a solid investment opportunity, Anthem is definitely worth considering.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,868,882 | +0.8% | 3,449 | -3.6% | 0.06% | -1.6% |
| Q1 2024 | $1,854,305 | +13.6% | 3,576 | +3.4% | 0.06% | +4.9% |
| Q4 2023 | $1,631,601 | +7.1% | 3,460 | -1.1% | 0.06% | -3.2% |
| Q3 2023 | $1,523,967 | -8.4% | 3,500 | -6.5% | 0.06% | -3.1% |
| Q2 2023 | $1,664,000 | -1.9% | 3,745 | +1.5% | 0.06% | -4.4% |
| Q1 2023 | $1,697,000 | -12.8% | 3,690 | -2.7% | 0.07% | -9.3% |
| Q4 2022 | $1,945,000 | +8.9% | 3,792 | -3.5% | 0.08% | -1.3% |
| Q3 2022 | $1,786,000 | -1.5% | 3,931 | +4.6% | 0.08% | +4.1% |
| Q2 2022 | $1,814,000 | -4.2% | 3,758 | -2.5% | 0.07% | +14.1% |
| Q1 2022 | $1,893,000 | +1.2% | 3,853 | -4.6% | 0.06% | +8.5% |
| Q4 2021 | $1,871,000 | +22.2% | 4,037 | -1.7% | 0.06% | +9.3% |
| Q3 2021 | $1,531,000 | -9.9% | 4,106 | -7.8% | 0.05% | 0.0% |
| Q2 2021 | $1,700,000 | +3.8% | 4,452 | -2.4% | 0.05% | -3.6% |
| Q1 2021 | $1,638,000 | -18.2% | 4,562 | -26.9% | 0.06% | -16.4% |
| Q4 2020 | $2,003,000 | +12.9% | 6,240 | -5.5% | 0.07% | +1.5% |
| Q3 2020 | $1,774,000 | +36.3% | 6,604 | +33.4% | 0.07% | +32.0% |
| Q2 2020 | $1,302,000 | +13.9% | 4,950 | -1.7% | 0.05% | +11.1% |
| Q1 2020 | $1,143,000 | -62.2% | 5,036 | -49.7% | 0.04% | -54.1% |
| Q4 2019 | $3,026,000 | +3.2% | 10,019 | -17.9% | 0.10% | +2.1% |
| Q3 2019 | $2,931,000 | -16.4% | 12,205 | -1.8% | 0.10% | -14.3% |
| Q2 2019 | $3,508,000 | -10.4% | 12,431 | -8.8% | 0.11% | -11.1% |
| Q1 2019 | $3,914,000 | +3.5% | 13,637 | -5.2% | 0.13% | -1.6% |
| Q4 2018 | $3,780,000 | -6.0% | 14,392 | -2.0% | 0.13% | +12.3% |
| Q3 2018 | $4,023,000 | +65.4% | 14,681 | +43.7% | 0.11% | +1.8% |
| Q2 2018 | $2,432,000 | +5.1% | 10,217 | -3.0% | 0.11% | +7.7% |
| Q1 2018 | $2,315,000 | -3.9% | 10,537 | -1.5% | 0.10% | +4.0% |
| Q4 2017 | $2,408,000 | +6.1% | 10,700 | -10.4% | 0.10% | +4.2% |
| Q3 2017 | $2,269,000 | -6.2% | 11,948 | -7.0% | 0.10% | -5.9% |
| Q2 2017 | $2,418,000 | +7.9% | 12,853 | -5.1% | 0.10% | +9.7% |
| Q1 2017 | $2,240,000 | +87.1% | 13,548 | +58.5% | 0.09% | +86.0% |
| Q3 2015 | $1,197,000 | -7.6% | 8,550 | +1.9% | 0.05% | +2.0% |
| Q2 2015 | $1,296,000 | 0.0% | 8,390 | 0.0% | 0.05% | 0.0% |
| Q1 2015 | $1,296,000 | +43.4% | 8,390 | +16.7% | 0.05% | +44.1% |
| Q4 2014 | $904,000 | – | 7,190 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 170,700 | $28,019,000 | 14.31% |
| METROPOLITAN CAPITAL ADVISORS INC | 45,737 | $7,507,000 | 5.95% |
| Firefly Value Partners, LP | 290,000 | $47,601,000 | 5.82% |
| FORT, L.P. | 67,579 | $11,092,000 | 5.76% |
| Robertson Opportunity Capital, LLC | 40,710 | $6,682,000 | 5.17% |
| NEEDELMAN ASSET MANAGEMENT INC | 9,255 | $1,519,000 | 4.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,046,984 | $171,852,000 | 4.49% |
| Focused Investors LLC | 743,400 | $122,022,000 | 4.23% |
| Raveneur Investment Group LP | 68,200 | $11,194,000 | 4.04% |
| Steigerwald, Gordon & Koch Inc. | 54,704 | $8,770,000 | 3.99% |